clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Study Suggests Cytomegalovirus Could Contribute to Alzheimer’s Pathology in Certain Individuals
News & Features
Mutated Cilia Implicated in Pathology of ALS
Informatics
New SMART Software Revolutionizes Cell Signaling Simulations
Coronavirus
Genetic Importance for Flu Vaccine Protection Could Broaden Pandemic Preparedness
Informatics
Brain Structure Linked with Dyslexia Predisposition
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
The Breadth of Precision Medicine at ASCO 2019: From early detection to progress in difficult-to-treat cancers and previously undruggable targets
Pancreatic cancer
News & Features
The Breadth of Precision Medicine at ASCO 2019: From early detection to progress in difficult-to-treat cancers and previously undruggable targets
Cindy Perettie
July 16, 2019
0
Molecular Dx
Foundation Medicine CEO Cindy Perettie’s Top ASCO 2019 Takeaways
June 12, 2019
0
News & Features
Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor
June 3, 2019
0
Molecular Dx
Thrive Launches with $110M and Johns Hopkins-developed Cancer Liquid Biopsy Tech
May 30, 2019
0
News & Features
Single Gene Deletion Halts Pancreatic Cancer in Mice
May 2, 2019
0
News & Features
Genetic Signatures May Aid in Early Detection of Pancreatic Cancer
March 4, 2019
0
Molecular Dx
Tongue Key to Early Pancreatic Cancer Diagnosis?
February 1, 2019
0
News & Features
VISTA Molecule a Target for Pancreatic Cancer Immunotherapy
January 14, 2019
0
Molecular Dx
Sysmex, MolecularMD Partner on Precision Medicine Companion Diagnostics
November 29, 2018
0
News & Features
Open Source Tool Predicts Chemo Drugs Best Suited for Individual Patients
November 7, 2018
0
1
...
14
15
16
17
Page 15 of 17
Related Content
First Synovial Fluid Biomarker Test Accurately Diagnoses Primary Osteoarthritis
Not All Precision Medicine Heroes Wear Lab Coats
Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine
MRI Technique Detects Pre-Malignant Pancreatic Cancer Lesions
Inside Precision Medicine
![A three-protein biomarker panel has been established that is able to screen urine samples for signs of early-stage pancreatic cancer. [iStock/© David Marchal]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/289.jpeg "Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor")
![Sysmex and MolecularMD will partner to develop and commercialize companion diagnostics for precision medicines through a master collaboration agreement whose value was not disclosed.[© Alex Tihonov/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/2029.jpeg "Sysmex, MolecularMD Partner on Precision Medicine Companion Diagnostics")
